2016 中国冠状动脉血运重建适宜性标准的建议(试行)

2016-04-01 中国循环杂志.2016,31(4):313-137.

2015 年初受国家卫生计生委的委托,国家心血管病中心起草了《中国冠状动脉血运重建的适宜性标准的建议(试行)》,主要目的有二:一是希望能够指导临床医生合理选择PCI 和CABG;另一方面,也希望能够一定程度上评价医院对PCI 指证的选择情况,以判断医院是否存在应用不适宜的问题。

中文标题:

2016 中国冠状动脉血运重建适宜性标准的建议(试行)

发布机构:

发布日期:

2016-04-01

简要介绍:

2015 年初受国家卫生计生委的委托,国家心血管病中心起草了《中国冠状动脉血运重建的适宜性标准的建议(试行)》,主要目的有二:一是希望能够指导临床医生合理选择PCI 和CABG;另一方面,也希望能够一定程度上评价医院对PCI 指证的选择情况,以判断医院是否存在应用不适宜的问题。

制定者: 
国家心血管病中心 
《中国冠状动脉血运重建适宜性标准的建议》工作组


冠状动脉血运重建相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 中国冠状动脉血运重建适宜性标准的建议(试行))] GetToolGuiderByIdResponse(projectId=1, id=33c351c001232301, title=2016 中国冠状动脉血运重建适宜性标准的建议(试行), enTitle=, guiderFrom=中国循环杂志.2016,31(4):313-137., authorId=null, author=, summary=2015 年初受国家卫生计生委的委托,国家心血管病中心起草了《中国冠状动脉血运重建的适宜性标准的建议(试行)》,主要目的有二:一是希望能够指导临床医生合理选择PCI 和CABG;另一方面,也希望能够一定程度上评价医院对PCI 指证的选择情况,以判断医院是否存在应用不适宜的问题。, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Apr 01 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<div>2015 年初受国家卫生计生委的委托,国家心血管病中心起草了《中国冠状动脉血运重建的适宜性标准的建议(试行)》,主要目的有二:一是希望能够指导临床医生合理选择PCI 和CABG;另一方面,也希望能够一定程度上评价医院对PCI 指证的选择情况,以判断医院是否存在应用不适宜的问题。</div> <div><br> </div> <span style="font-weight: bold;">制定者: </span> <div>国家心血管病中心 </div> <div>《中国冠状动脉血运重建适宜性标准的建议》工作组</div> <div><br> </div> <div><br> </div> <strong>与<font color=red>冠状动脉血运重建</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=33c351c001232301" title="2016 中国冠状动脉血运重建适宜性标准的建议(试行)" target=_blank>2016 中国冠状动脉血运重建适宜性标准的建议(试行)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=292df1c00088e3a6" title="2012ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 冠状动脉血运重建术应用标准更新" target=_blank>2012ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 冠状动脉血运重建术应用标准更新</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89%E8%A1%80%E8%BF%90%E9%87%8D%E5%BB%BA" target=_blank>有关冠状动脉血运重建更多指南</a></ul>, tagList=[TagDto(tagId=9761, tagName=冠状动脉), TagDto(tagId=1497, tagName=血运重建)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=null, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3122, appHits=131, showAppHits=0, pcHits=2168, showPcHits=1270, likes=140, shares=3, comments=4, approvalStatus=1, publishedTime=Fri Jul 08 16:00:17 CST 2016, publishedTimeString=2016-04-01, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Fri Jul 08 16:00:17 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:22:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 中国冠状动脉血运重建适宜性标准的建议(试行))])
2016 中国冠状动脉血运重建适宜性标准的建议(试行)
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=105220, encodeId=111e10522047, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:27:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92412, encodeId=6a7292412f7, content=很有用 已下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/22/ee7687e9e5fb7c279b06305d88126b21.jpg, createdBy=ebcd1655847, createdName=积分超人, createdTime=Fri Jul 08 17:59:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92398, encodeId=85d792398e9, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Fri Jul 08 16:51:00 CST 2016, time=2016-07-08, status=1, ipAttribution=)]
    2016-08-27 1e0f7307m29(暂无匿称)

    实用,特别实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=105220, encodeId=111e10522047, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:27:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92412, encodeId=6a7292412f7, content=很有用 已下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/22/ee7687e9e5fb7c279b06305d88126b21.jpg, createdBy=ebcd1655847, createdName=积分超人, createdTime=Fri Jul 08 17:59:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92398, encodeId=85d792398e9, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Fri Jul 08 16:51:00 CST 2016, time=2016-07-08, status=1, ipAttribution=)]
    2016-07-08 积分超人

    很有用 已下载

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=105220, encodeId=111e10522047, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:27:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92412, encodeId=6a7292412f7, content=很有用 已下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/22/ee7687e9e5fb7c279b06305d88126b21.jpg, createdBy=ebcd1655847, createdName=积分超人, createdTime=Fri Jul 08 17:59:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92398, encodeId=85d792398e9, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Fri Jul 08 16:51:00 CST 2016, time=2016-07-08, status=1, ipAttribution=)]
    2016-07-08 黄庆

    0